This Technical Report identifies important quality management system elements for non-regulated biomedical research in drug development in order to ensure credibility of biomedical research results. This includes both large and small molecule discovery and non-clinical development that is not covered by GxP.
The target audience for this report is the scientific staff at institutions and companies involved in drug development. Compliance with applicable regulatory and safety requirements is not covered by this report.
This Technical Report was created by a working group from the Food, Drug and Cosmetic Division of the American Society for Quality.
Document identifier
ASQ TR1-2012
Title
Best quality practices for biomedical research in drug development
Publication date
0000-00-00
International Relationship
| Price |
59 vnd |
.jpg){kind=logo}
---Logo.jpg){kind=logo}
.jpg){kind=logo}
-_-logo.png){kind=logo}
.jpg){kind=logo}
.png)
